AP NEWS

Global DNA Vaccine Market Outlook 2018-2022 - ResearchAndMarkets.com

June 5, 2018

DUBLIN--(BUSINESS WIRE)--Jun 5, 2018--The “Global DNA Vaccine Market Outlook 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

This comprehensive report entitled Global DNA Vaccine Market Outlook 2022 provides an in-depth analysis of the global DNA Vaccines market, presenting readers with a profound understanding of the various challenges, drivers, and developments in this industry.

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. Various vaccines have been introduced in the market based on this technique.

Some of the major DNA vaccines include GlaxoSmithKline’s Engerix-B, Twinrix, and Fendrix; Merck’s Gardasil, and Recombivax HB; Protein Sciences Corporation’s Flublok, etc. Currently, the researchers are engaged in developing genetic vaccines for humans. Animal genetic vaccines are already present in the market. These vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into host body and produces protein for which the body generates immune response.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. DNA Vaccine - An Introduction

4. Drivers & Challenges

5. DNA Vaccine Market Overview

6. DNA Vaccines Market by Geography

7. DNA Vaccine Market by Type

8. DNA Vaccines Market by End User

9. DNA Vaccines Market by Therapeutic Indication

10. Pipeline Analysis

11. Trends

12. Company Profiles

13. Recommendations

Companies Mentioned

Novartis International AG Merck & Co., Inc GlaxoSmithKline plc. Sanofi Zoetis Green Cross Corporation Inovio Pharmaceuticals, Inc., Bharat Biotech Protein Sciences Corporation Indian Immunologicals Ltd. Serum Institute of India Pvt. Ltd

For more information about this report visit https://www.researchandmarkets.com/research/b2l2rh/global_dna?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180605005941/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Vaccines

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/05/2018 08:10 AM/DISC: 06/05/2018 08:10 AM

http://www.businesswire.com/news/home/20180605005941/en

AP RADIO
Update hourly